Mr Mark Waddell > Loeb & Loeb LLP > New York, United States > Lawyer Profile

Loeb & Loeb LLP‘s chiefly New York based practice handles the full scope of life sciences mandates, including adverse event reporting and response, patent enforcement, and the approval of biosimilars and biologics products. Fran Stoller advises both public and private biotech, pharmaceutical, and technology companies on corporate and financing transactions, in addition to research and development collaborations. Mark Waddell handles the patent litigation side of the practice, representing drug companies in biosimilars and Hatch-Waxman related matters concerning exclusivity protection. Mitchell Nussbaum maintains a corporate and capital markets focused practice, routinely advising on private placements, IPOs, and proxy contests.